Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
about
Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosisEffects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patientsState of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.Reduced interleukin-8 production by cystic fibrosis airway epithelial cellsVaccines for Pseudomonas aeruginosa: a long and winding roadGenetics of susceptibility to human infectious diseaseHyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cellsIsolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesisEvidence that WapB is a 1,2-glucosyltransferase of Pseudomonas aeruginosa involved in Lipopolysaccharide outer core biosynthesisMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaLung infections associated with cystic fibrosis.Relating the physical properties of Pseudomonas aeruginosa lipopolysaccharides to virulence by atomic force microscopy.Characterization of the lipopolysaccharide from a wbjE mutant of the serogroup O11 Pseudomonas aeruginosa strain, PA103.Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa.Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccinePseudomonas aeruginosa interacts with epithelial cells rapidly forming aggregates that are internalized by a Lyn-dependent mechanism.Elucidation of the structure of an alanine-lacking core tetrasaccharide trisphosphate from the lipopolysaccharide of Pseudomonas aeruginosa mutant H4.Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductanWbpO, a UDP-N-acetyl-D-galactosamine dehydrogenase from Pseudomonas aeruginosa serotype O6.Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa binding, internalization, and initiation of inflammationPseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.Common CFTR gene variants influence body composition and survival in rural Ghana.Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spreadThe pathogenic consequences of a single mutated CFTR gene.Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa.Update in cystic fibrosis 2012.Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammationMicrobial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)A mild variant of cystic fibrosis.Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infectionAugmentation of pulmonary host defense against Pseudomonas by FcgammaRIIA cDNA transfer to the respiratory epithelium.Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.Cytolysin-dependent evasion of lysosomal killingMolecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages.
P2860
Q24548775-70274C00-E1AA-4CB9-A197-93351457413FQ24551181-39E8BD5A-6026-4D58-AA8E-C31C31E012B8Q24802489-A49A7E4D-6213-4E83-BFFB-56971656CA9BQ24807172-3C875B24-621D-4D6D-B9F5-F1E82108D589Q26341680-4AE41174-82CD-4488-881B-15F326663DABQ26852817-8DA75FF4-8C19-4DAF-BDCA-377440A3AF55Q28208872-78545AF0-69EA-49EE-ABBC-E830D5A2E26FQ28216541-976A9B30-D56D-4860-9E37-9DE84EC4EAC9Q28492471-6F3CE7E6-FAEF-4934-976D-8208B66EE9C1Q28492937-46F70D6E-8DBB-4A5A-B69F-5CC4CC9B8D4EQ29615286-50AFC0C0-532D-4DB5-A54C-4F8E27C3DD85Q30080000-DA112C3E-1589-4734-9EB6-7863586B1B84Q30430880-80279CFA-62DF-49E0-8F02-EC8D90709A2BQ30443596-E950FC60-CD2F-4892-83DE-20D442356A34Q30445858-675F5D2C-9EA8-4E30-BDAF-2E2EC71B6D8BQ30453151-D0476382-3BE1-43C7-BAA0-A784B574C9C1Q30453226-1BFE2297-E192-4CBA-9D93-361EF63EE8D4Q30555799-1DA50708-C59E-4075-8D37-D4FD9B1DB2DEQ30573536-C861E82B-A675-4D06-8E0B-A2200B732FD8Q30833376-5DBA1EB1-9EDC-4773-8B59-660F85A77B85Q31423575-CA4A0B9F-C796-43EC-82C9-E6D285E21949Q33208286-50AC8BA8-E5DB-47EB-B5E0-25F4F86B00BCQ33508834-8A8A75EF-9482-4819-9A8F-01B9EDDEA194Q33590716-EB8C23F5-D4E8-49FF-9C8A-1E2745290A38Q33596653-07981E4C-D648-45D3-AD30-68BC845BD389Q33714004-90E75D2E-9DB0-4F40-AAE1-D7898A8581C7Q33728775-CA8C2A95-8BCB-40E1-81E6-1ADEDDE5E5ADQ33738510-6136E09E-E3BA-465E-8F0D-2EBDA708839CQ33738695-D3CA158E-2AE3-40F4-B687-79757731C7A6Q33748666-CB29FADB-2D16-469A-B94B-8300D2D0A905Q33752721-1A94DFDD-A255-4F40-8B3F-38D95BF028C9Q33774155-8C09C168-C998-4E20-B79B-FA61E70E3ACBQ33776129-AF310D64-F445-41C9-84CE-A8EACA5DC2E6Q33815381-CA9F8D7F-C85F-4778-9C06-0E1E4CFE8280Q33857260-BB26FB7A-9269-4604-BD50-AEBF5E8482A5Q33897664-6163004A-B84A-454F-A574-D8BFDE1168A5Q33935020-E08965A1-F1B2-4927-B842-314F5FB0FA4AQ33950252-068DA1CF-774B-407C-97FA-10EDBD7F3608Q33988505-18CF16CA-E6D3-4E89-A191-42A99DC3278EQ33999861-C4931199-56DA-4DC1-8695-7B01AD46E4CB
P2860
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@ast
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@en
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@nl
type
label
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@ast
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@en
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@nl
prefLabel
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@ast
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@en
Role of mutant CFTR in hypersu ...... s patients to lung infections.
@nl
P2093
P2860
P1433
P1476
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
@en
P2093
J B Goldberg
J R Yankaskas
L G Johnson
P2860
P356
10.1126/SCIENCE.271.5245.64
P407
P50
P577
1996-01-01T00:00:00Z